Best Online Consultation with Oncologist Doctors in Spain — TOP 12

Dr. Francesc Cobo Valien graduated from the Faculty of Medicine of the University of Barcelona in 1990.

He received his specialization in oncohematology at the Hospital Clínic de Barcelona in 1995. He combined medical practice and research activities in the period 1996-2002.

He received his Doctor of Medicine degree from the University of Barcelona in 2002.

Dr. Kobo continues his research and has been awarded grants:

•Interdepartmental Commission for Innovation of the Generalitat de Catalunya

•Scholarship Fund Universitaria Agustí Pedro i Pons

•Farreras Valentí & Schering Plough School of Hematology Scholarship

•Award for the best report at the Council of the Spanish Hematology Association

•Grant from the Catalan Society of Hematology

Specialization:

•Lymphoma

•Acute leukemia

•Chronic leukemia

•Autoimmune pancytopenia

Dr. Balaña received her medical degree from the Central University of Barcelona and completed her residency in medical oncology at one of the best public hospitals in Spain, Vall d'Hebrón Hospital.

She was a leading specialist in the treatment of brain tumors at the Institute of Oncology of Catalonia, a founding member and current president of the Spanish Neuro oncology Research Group (GEINO), and a member of the scientific committee of the European Association for Neuro-Oncology.

He is the recipient of prestigious research grants in the field of brain tumors.

Dr. Balaña is also a member of the European Society of Medical Oncology and the author of modern European protocols for the treatment of brain tumors, as well as the protocols of the Spanish Society of Medical Oncology (SEOM).

Dr. Balaña has published over 400 articles, books and scientific papers at national and international conferences.

He is the author of articles in prestigious scientific publications such as:

Lancet Oncology;

Nature Reviews in Clinical Oncology;

Clinical Cancer Research and others.

Dr. Lana Bijelic is a surgical oncologist at Centro Médico Teknon in Barcelona. She has performed over 1,300 surgeries for complex cancer cases. Dr. Bijelic specializes in treating carcinomatosis and liver metastases. She trained under Prof. Paul Sugarbaker, a pioneer in peritoneal surface oncology. Her clinical practice includes international experience in the US, Spain, and Croatia.

• Certified by the American Board of Surgery.
• Performs HIPEC and complex resections for gastrointestinal cancers.
• Former Research Director in the Department of Surgery at Inova Fairfax Hospital.
• Member of the Society of Surgical Oncology and the American College of Surgeons.

Dr. Enriqueta Felip is a clinical oncologist at Hospital Quiron Barcelona. She lead the 20th WCLC Congress as co-chair. Dr. Felip manages thoracic malignancies and oversees cancer clinical trials. She earned her medical degree and PhD from the Autonomous University of Barcelona.

• President of the Oncology Commission at Vall d’Hebron University Hospital.
• Winner of the first ESMO Women for Oncology Award.
• Former Vice-President of the Spanish Society of Medical Oncology.
• Served on the Board of Directors for the International Association for the Study of Lung Cancer.

Dr. Francesc Bosch is a world-renowned expert in chronic lymphocytic leukemia and lymphoma. He leads the Hematology Department at Vall d’Hebron University Hospital in Barcelona. Dr. Bosch currently manages over 80 clinical trials focused on new drug development. He is also the Head of Hematology at the IOB Institute of Oncology.

• President of the Spanish Group for the Study of Chronic Lymphocytic Leukemia.
• Published over 100 articles in journals like Nature Medicine and Blood.
• Completed a two-year fellowship at Columbia University’s Institute of Cancer Genetics.
• Treats complex hematological conditions at JCI-accredited Hospital Quiron Barcelona.

Dr. Ana Oaknin is a gynecologic oncologist at Hospital Quiron Barcelona. She serves as Co-Chair of the GEICO Group for ovarian cancer research. Dr. Oaknin leads the Gynaecological Tumour Unit at the Vall d’Hebron University Hospital. She is a faculty member for the European Society of Medical Oncology.

• Acts as Principal Investigator for clinical trials in ovarian, cervical, and endometrial cancer.
• Authored over 100 scientific publications and conference presentations.
• Specializes in immunology, DNA repair mechanisms, and immunotherapy.
• Works at JCI-accredited Hospital Quiron Barcelona, a top-ranked clinic in Spain.

Dr. Jesus Soberino is a clinical oncologist at Hospital Quiron Barcelona. He focuses on breast cancer and melanoma treatments. Dr. Soberino is a member of the Breast Cancer and Melanoma Units at Vall d’Hebron.

• Participated in trials approving palbociclib and ribociclib for metastatic breast cancer.
• Researched immunotherapy drugs leading to the approval of Pembrolizumab for melanoma.
• Contributed to trials for the melanoma drug combination of Nivolumab and Ipilimumab.
• Practices at the JCI-accredited Hospital Quiron Barcelona.

Dr. Aleix Prat is a clinical oncologist at Hospital Quiron Barcelona. He specializes in gene expression and molecular subtypes of breast cancer. Dr. Prat serves as the President of the Board of Directors at SOLTI. He leads the breast cancer program at IOB-Quirón Salud.

• Holds three patents for breast cancer research and diagnostics.
• Authored over 160 publications with more than 13,400 citations.
• Served as an executive committee member of the Breast International Group.
• Works at a JCI-accredited hospital collaborating with major US centers.

Key facts and achievements

• - More than 20 years of experience in the treatment of complex pathologies of the brain using Gamma Knife radiosurgery , including functional disorders and tumor diseases.
• -Works in a team with Dr. Roberto Martinez Alvarez , a world-leading neurosurgeon and Gamma Knife specialist, providing a unique multidisciplinary approach to patient care.
• - International experience : Studied and collaborated with leading global institutions, including the Gregorio Marañon in Madrid and the Gustave Roussy Institute in Paris.

Specialization

• More than 7,000 patients have been treated in the Radiosurgery Department, including:
• - Benign tumors : meningiomas, schwannomas, pituitary adenomas.
• - Malignant pathologies : brain metastases and CNS tumors.
• - Vascular pathologies : arteriovenous malformations, cavernomas and fistulas.
• - Functional disorders : refractory epilepsy, tremor, trigeminal neuralgia and obsessive-compulsive disorder.

Scientific and professional activities

• - Member of the international Gamma Knife Consortium , led by the University of Pittsburgh .
• - Author of scientific research and protocols for the treatment of cancer using radiotherapy.
• - Participated in the development of the innovative project "Fusion of Medical Images" as part of oncology research.

Experience

2002-present | Attached to the Department of Gamma Radiosurgery and Functional Neurosurgery of Ruber International Hospital.

2002-2007 | Assistant, Department of Radiation Oncology, Ruber International Hospital.

2002| Medical Affairs Manager Medical Department Janssen-Cilag, SA Madrid

Qualification

2012|Doctor of Medicine and Surgery Madrid. Department of Surgery, Autonomous University of Madrid. Spain

2001 | Specialist in Radiation Oncology at the Gregorio Marañón University Hospital in Madrid. Training completed at the Gustave-Roussy Institute in Paris in 2000.

1995 | Graduate of the Faculty of Medicine and Surgery, Complutense University of Madrid. Spain.

2016-present | Member of the Ruber International Hospital Gamma Knife Radiosurgery Team, International Gamma Knife Consortium: Led by the Pittsburgh Hospital.

1999-2000| Project Manager: "Protocol for Pamidronate Treatment of Breast Cancer Patients with Predominantly Lytic Bone Metastases"

1999 | GICOR Study: "Incidence of Anemia in Patients Receiving Radiation Therapy"

1999 | GICOR study: "Androgen deprivation protocol associated with radiation therapy for localized high-risk prostate cancer"

1997-2001|Participant (collaborator) in the research project (FIS FELLOWSHIP): "Multimodal fusion of medical images in oncology" at HGU Gregorio Marañon. Project leader: Dr. Desco Menéndez.

Teaching :

2018-present|Professor of the International Master of Radiosurgery of the Central Nervous System at the Complutense University of Madrid.

2020-present|Professor at the School of Radiosurgery of the Spanish Society of Neurosurgeons.

2017-2019|Professor of the Master of Radiosurgery and Clinical Stereotactic Radiotherapy of the Spanish Society of Radiation Oncology.

2017 - 2022| Member of the Dissertation Committee in Radiosurgery three times at the Autonomous University of Madrid and the Complutense University of Madrid.

2011-2012|Professor, International Master's Program in Advanced Technological Applications in Radiation Oncology, 3rd ed.

2001-2002|Associate Professor of Dentistry at the Alfonso X El Sabio University.

1998 - 2001|Professor of the secondary school I.E. Technical and vocational school of health K.A.M. (Radiation oncology technicians and archival technicians).

Publications

2022|Stereotactic radiosurgery of obsessive-compulsive disorders. Chapter. 25. Book: Intracranial stereotactic radiosurgery. ed. 2022. Pages: 251-256.

2022|Active monitoring and stereotactic radiosurgery provide a low risk of symptoms associated with incident frontobasal meningioma, but stereotactic radiosurgery provides better radiological control – a subanalysis of the IMPASSE trial. Cancers 2022; 14(5).1300. https://doi.org/10.3390/cancers14164047

2022|Stereotactic radiosurgery for Kuss grade IV vestibular schwannoma: a multi-institutional study. Journal of Neurosurgery. 2022 Jun 3; DOI: 10.3171/2022.4.JNS22203.

2022|Stereotactic radiosurgery for Rathke's cleft cyst: an international multicenter study. J Neurosurg 137: 1041–1046, 2022. DOI: 10.3171/2021.12.JNS212108.

2021|Surgery and radiosurgery in autism: a retrospective study on 10 patients. Stereotactic Function Neurosurgery. 2021;99(6):474–483. 15.

Presentations

2019| "Other indications in malignant tumor pathology" Cranial Radiosurgery Conference. Valencia 2019.

2018| Gamma Knife Radiosurgery: Concept, Equipment and Treatment Description I Scientific Conference on Gamma Knife Radiosurgery, Madrid, 2018

2018|Radiotherapy and protons in children. XX meeting of the SENEC Working Group on Neuro-Oncology:. Madrid.

2015| "Visualization monitoring of response and complications of brain treatment". XVIII National Congress of S.E.O.R. Valencia

2015 | Gamma Knife Radiosurgery in the Treatment of Refractory Epilepsy Associated with Nodular Heterotopia: Long-Term Safety and Efficacy. Congress of the Spanish Society of Neurology.

Communities it belongs to:

-SER, Spanish Society of Radiosurgery (she currently serves on the Board of Directors as Treasurer)

-SEOR, Spanish Society of Oncological Radiotherapy: Working Groups "Brain Tumors (NEUROONCOR)" and "Radiation Oncology Activities in the Private Sector"

-SSRI, International Society for Stereotactic Radiosurgery

- Member of the Oncology Group of the Spanish Society of Neurosurgery (SENEC).

Dr. Nuria Martínez Moreno , working in tandem with Dr. Roberto Martínez Álvarez, combines expert oncology knowledge and high-precision radiosurgery technology , providing patients with the most advanced and effective treatment in Spain.

Dr. Francesc Graus is a neuro-oncologist at Hospital Quiron Barcelona. He founded the European Association of Neuro-Oncology (EANO). Dr. Graus identified the antibodies now used globally to diagnose autoimmune neurological dysfunctions. He completed a neuro-oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York.

• Former President of the European Association of Neuro-Oncology.
• Served as Chief of Neurology at Hospital Clinic Barcelona.
• Treats brain tumors including gliomas, glioblastomas, and primary brain lymphomas.
• Holds a Doctor Honoris Causa from Lyon University.

The doctor is an experienced specialist in children's hematology oncology and a leading pediatric neurosurgeon in Spain. With over 30 years of practical experience, the doctor leads the Hematology & Pediatric Oncology Unit at HM Hospitales, focusing on severe hematological and cancer diseases in children and teens.

The doctor specializes in the diagnosis and treatment of hematological and cancer disorders, particularly in the erythrocyte, myeloid, and lymphoid systems. The doctor serves as a WHO and UNESCO consultant and is involved in teaching and research activities.

Educational credentials include degrees from the Universidad Complutense de Madrid, the University of Barcelona, and the University of Maryland.

The doctor is an accomplished educator and researcher in the field of oncology, with extensive teaching experience at USP CEU. The doctor has taught a wide array of subjects including General Medical Pathology, Oral and Maxillofacial Oncology, and Bioethics. As a tutor for medical students and external rotants, the doctor has contributed significantly to the training of future healthcare professionals.

Additionally, the doctor holds the position of Director of postgraduate research in clinical and applied oncology at HM CIOCC USP CEU and is responsible for postgraduate master practices. The doctor has also completed advanced courses at MD Anderson Cancer Center.